IB
iShares Biotechnology ETF (IBB)
NASDAQ
212.56
-1.00 (-0.47%)
Closed
Aug 24, 2026
Day's Range
210.13212.96
52 wk Range
136.89217.06
Overview - IBB - iShares Biotechnology ETF
Key Statistics
Valuation
P/E (Trailing)
‪27.70‬
Price stats
50-Day Avg
‪190.37‬
200-Day Avg
‪174.96‬
Dividends
Frequency
Quarterly
Market Cap - IBB - iShares Biotechnology ETF
Peers - IBB - iShares Biotechnology ETF
Peer Comparison
Compared with other ETFs.
- IBIBBNASDAQiShares Biotechnology ETF11.78BMarket Cap+35.09%52-week change27.70P/E (Trailing)—Profit Margin
- DVYNASDAQiShares Select Dividend ETF26.67BMarket Cap+13.96%52-week change16.15P/E (Trailing)—Profit Margin
- DUDUKHNASDAQOcean Park High Income ETF16.90BMarket Cap-3.07%52-week change15.67P/E (Trailing)—Profit Margin
- CSBNASDAQVictoryShares US Small Cap High Div Volatility Wtd ETF13.02BMarket Cap+11.66%52-week change14.94P/E (Trailing)—Profit Margin
- CSCSBIXNASDAQCromwell Balanced Fund Institutional Class6.82BMarket Cap+0.00%52-week change24.96P/E (Trailing)—Profit Margin
- CALYNASDAQBlackRock Short-Term California Muni Bond ETF2.83BMarket Cap+39.08%52-week change36.95P/E (Trailing)‪-12.36%‬Profit Margin
- DVGRNASDAQDAC 3D Dividend Growth ETF1.40BMarket Cap+8.10%52-week change24.20P/E (Trailing)‪19.40%‬Profit Margin
Profile Summary - IBB - iShares Biotechnology ETF
About
iShares Biotechnology ETF is an exchange-traded fund that seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. Launched in 2001 and managed by BlackRock, it provides investors with targeted exposure to companies engaged in the research, development, and…
Employees0
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
